Wednesday, April 4, 2007

GenVault Corporation Raises $18 Million of Financing

GenVault Corporation, the leader in room temperature biosample management, announced today that the company has successfully closed an additional $18 million in venture financing. QuestMark Partners joins Domain Associates as GenVault’s investor. In conjunction with this transaction, Benjamin S. Schapiro, Partner at QuestMark Partners, will join GenVault’s Board of Directors.

The funds will be used to accelerate commercialization of GenVault proprietary technologies in room temperature biosample storage and transport for genomic discovery, healthcare and forensic applications.

Mr. Schapiro commented, “GenVault management and technology are clearly poised to transform fundamental niches within several major industries worldwide, from drug discovery, to forensics, to healthcare management and delivery. The Company has a proven track record in delivering significant value to its pharmaceutical, academic and forensics customers. We are anticipating a highly productive collaboration.”

“The support of a firm of the caliber such as QuestMark, and the continued support of Domain, mark a great accomplishment for the GenVault team,” said David Wellis, Ph.D., CEO of GenVault. “The addition of this significant capital will enable expansion of our global sales and marketing programs, production, and ultimately, market penetration, in several multibillion dollar markets.

This milestone marks a gratifying endorsement of both GenVault’s novel technology, as well as recognition of an unusual opportunity to grow diverse industrial, academic and government markets worldwide.”

The company’s technology and business model meet a growing demand for reliable, sophisticated biosample management in industries where this is critical for accurate, cost effective processes and outcomes,” said James C. Blair, Ph.D., Partner at Domain Associates. . “Our continued investment is worthy of this unique technologic and commercial opportunity.”

About GenVault
GenVault is the leader in providing DNA sample accessibility for genomic discovery, medicine and identification. GenVault serves customers across medical centers, academic institutions, pharmaceutical companies, and law enforcement agencies. As a scalable and reliable alternative to traditional freezers and DNA purification systems, GenVault's dry-state platform enables the extraction, preservation, recovery and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From its GenPlate to its Dynamic Archive solution, GenVault is continuously developing and refining best practices for DNA sample management.

About Questmark Partners
QuestMark Partners is a venture capital firm focused on late-stage growth companies in emerging markets. QuestMark's areas of focus includes in growth industries such as software, medical devices, and internet-based businesses, as well as enterprises in broader technology, health care and consumer areas. Founded in 1998, QuestMark has over $450 million under management.

About Domain Associates
Since the formation of Domain Associates in 1985, Domain's partners have been actively involved in the creation of venture capital backed enterprises that now form the backbone of the biotechnology industry. Companies receiving early venture financing and active involvement from Domain's partners today account for over $100 billion of stock market value and close to $12 billion in annual revenues. Domain provides approximately $100 million annually to U.S.-based ventures concentrating in the life sciences industries.

Shares of NYSE Euronext begin trading, marking the beginning of the first truly global financial marketplace

The shares of NYSE Euronext (NYSE Euronext: NYX) began trading today, first on Euronext in Paris at 9:00 a.m. (CET) and soon to follow in New York on the NYSE at 9:30 a.m. (EST). The opening share price on Euronext Paris for the newly merged company was €75. A total of 257,598,971 NYSE Euronext shares were admitted to listing. On the basis of the first price traded on Euronext, the market capitalization of NYSE Euronext stands at €19.32 billion/$25.81 billion[1], making the company the world's largest listed exchange group.
The debut of NYSE Euronext follows the successful combination of NYSE Group, Inc. (NYSE) and Euronext N.V. (Euronext). A global leader in listings, in equity and derivatives trading, in market data products and financial services technology, NYSE Euronext is the world’s largest and most liquid stock-market platform with average daily value of trading totaling some €90/$120 billion and capitalization of listed companies totaling €21,500/$28,500 billion.

Jan Michiel Hessels, Chairman, NYSE Euronext said: “As the first Chairman of the NYSE Euronext Board of Directors, I am extremely pleased and honored to be able to contribute to the success of our new company. The entire Board of NYSE Euronext feels responsible to develop a truly international company with a clear strategy for future growth and delivering synergies of $375/€ 292 million as promised to our clients and shareholders. ”

Marshall N. Carter, Deputy Chairman, NYSE Euronext, added: “This is an historic day for our new company, our industry, and global financial markets. This merger will create significant benefits to shareholders, our customers and all market participants including public investors and issuers. Through carefully identified synergies and a customer-driven focus, we are well positioned for future growth and value creation. Our shareholders and so many others deserve great thanks for their overwhelming support.”

John A. Thain, Chief Executive Officer, NYSE Euronext, said: “NYSE Euronext is the global leader and we have significant business opportunities ahead of us. We have 78 of top 100 largest companies in the world listed on NYSE Euronext markets, and we will continue to expand our global footprint and offer our customers a wider variety of trading products and services. As capital markets around the world consolidate, NYSE Euronext will play a central role in the development and definition of the new global marketplace.”

Jean-François Théodore, Deputy Chief Executive Officer, NYSE Euronext, said: “The creation of NYSE Euronext, with bases in the US and Europe, spanning the dollar and euro zone, will open the way for all participants to trade a broader range of products across extended time zones using harmonized trading platforms. Companies listed on Euronext markets will gain international visibility in addition to their existing exposure in Europe , through their presence on the world’s largest equity market group.”

About NYSE Euronext
NYSE Euronext, a holding company created by the combination of NYSE Group, Inc. and Euronext N.V., commenced trading on April 4, 2007 . NYSE Euronext (NYSE/New York and Euronext/Paris: NYX) operates the world’s largest and most liquid exchange group and offers the most diverse array of financial products and services. NYSE Euronext, which brings together six cash equities exchanges in five countries and six derivatives exchanges, is a world leader for listings, trading in cash equities, equity and interest rate derivatives, bonds and the distribution of market data. Representing a combined $28.5 trillion/€21.5 trillion total market capitalization of listed companies and average daily trading value of approximately $118.8 billion/€89.9 billion (as of February 28, 2007), NYSE Euronext seeks to provide the highest standards of market quality and integrity, innovative products and services to investors, issuers, and all users of its markets.

About NYSE Group, Inc.
NYSE Group, Inc., a wholly owned subsidiary of NYSE Euronext, operates two securities exchanges: the New York Stock Exchange LLC (the "NYSE") and NYSE Arca, Inc. (formerly known as the Pacific Exchange). NYSE Group is a leading provider of securities listing, trading and market data products and services.

The NYSE is the world’s largest and most liquid cash equities exchange. The NYSE provides a reliable, orderly, liquid and efficient marketplace where investors buy and sell listed companies’ common stock and other securities. NYSE Arca, the first open, all-electronic stock exchange in the United States , has a leading position in trading exchange-traded funds and exchange-listed securities. NYSE Arca is also an exchange for trading equity options. NYSE Arca’s trading platforms provide customers with fast electronic execution and open, direct and anonymous market access. NYSE Regulation, an independent not-for-profit subsidiary, regulates member organizations through the enforcement of marketplace rules and federal securities laws. NYSE Regulation also ensures that companies listed on the NYSE and NYSE Arca meet their financial and corporate governance listing standards.

About Euronext N.V.
Euronext N.V., a subsidiary of NYSE Euronext, has successfully integrated local markets across Europe to provide users with a unified market that is broad, liquid and cost effective. Euronext is the largest central order book cash market in Europe and the second largest derivatives exchange in the world, by value of business traded.

Following the initial three-way merger of the local exchanges of Amsterdam , Brussels and Paris , Euronext acquired the London-based derivatives market LIFFE and merged with the Portuguese exchange in 2002. Euronext’s unique business model incorporates the individual strengths and assets of each local market and has been implemented on all of Euronext’s markets, covers technological integration, the harmonisation of market rules and the regulatory framework. The implementation of Euronext’s horizontal model designed to generate synergies has proved that the most successful way to merge European exchanges is to apply global vision at a local level. Euronext’s IT integration was completed in 2004, when a four-year migration plan resulted in harmonised IT platforms for cash trading (NSC®) and derivatives (LIFFE CONNECT®). As a result, every market participant now has a single point of access to trading. Euronext’s IT structure was rationalized in 2005 with the creation of Atos Euronext Market Solutions (AEMS), an IT services-related vehicle between Euronext and Atos Origin which is now a leading global provider of technology services to Euronext and other global capital markets.



[1] The exchange rate on April 3, 2007 was $1.3358 to a euro

Tuesday, April 3, 2007

NASDAQ Introduces a China Equities Index

The Nasdaq Stock Market, Inc. (NASDAQ(r)) (Nasdaq:NDAQ) announced plans to introduce the NASDAQ China Index(sm) (Nasdaq:CHNX), which is designed to track the performance of the largest Chinese companies whose securities are listed and actively traded in the U.S. NASDAQ will begin disseminating the Index during the second quarter of 2007.

The NASDAQ China Index will be a key benchmark to track the performance of innovative companies that have stimulated one of the world's most rapidly growing and industrializing economies. The Index will initially be comprised of 30 Chinese companies with a combined market capitalization of more than $600 billion that are listed on NASDAQ, the New York Stock Exchange, or the American Stock Exchange. With the Index, NASDAQ will provide these companies with greater visibility and access from the U.S. to a large pool of investors worldwide.

"This Index will enable investors worldwide to follow companies in a broad range of industries that have helped propel one of the world's fastest growing and most successful economies over the last 20 years," said NASDAQ Executive Vice President John Jacobs. "China is on the verge of becoming the world's fourth-largest economy, a testament to the innovative companies that are included in this essential investment index."

Charlotte Crosswell, President of NASDAQ International, said, "The NASDAQ China Index highlights over two decades of NASDAQ's activity and commitment to the Chinese market. We are confident that the index will further enhance the visibility of the companies listing from China among U.S. and international investors."

The NASDAQ China Index will be calculated using a modified market capitalization methodology. Companies headquartered in China, inclusive of Hong Kong, which are listed on The NASDAQ Stock Market, the New York Stock Exchange, or the American Stock Exchange are eligible for Index inclusion. To be eligible, stocks must also have a minimum worldwide market capitalization of $200 million, a minimum average daily U.S. trading volume of 100,000 shares, and a minimum price of $3.00 per share.

NASDAQ is a force of innovation and influence in the financial products industry. It maintains its position as a world class innovator by developing new indexes of its own and with other partners. NASDAQ is home to some of the world's most closely watched indexes including the NASDAQ Composite Index(r), the NASDAQ-100 Index(r), the NASDAQ(r) Clean Edge(r) U.S. Liquid Series Index, and the NASDAQ Biotechnology Index(r). In addition to pursuing listings of exchange traded funds (ETFs) and other structured products, NASDAQ actively develops indexes and other index-based derivative securities for the global capital markets.

MicroCHIPS Receives Equity Investment from Leading Pharmaceutical Company


MicroCHIPS, Inc., a leading developer of innovative drug delivery and biosensing devices, today announced a $13.4 million dollar round of investment funding led by Novartis Venture Fund. Reinhard Ambros, Global Head of Novartis Venture Fund, has joined the company's board of directors. CSK Venture Capital of Japan also joined existing MicroCHIPS investors Polaris Venture Partners, IDG Ventures, Medtronic, Boston Scientific, Intersouth Partners and Boston University Community Technology Fund in this round of financing.

MicroCHIPS is pioneering the next generation of implantable biosensing and drug delivery devices that will improve therapeutic control, reduce painful interventions and help maintain and improve health for the millions of diabetes and osteoporosis sufferers worldwide.

According to Reinhard Ambros, Global Head of Novartis Venture Fund, "Novartis sees tremendous opportunity in the development of innovative devices that can be used to sense a patient's condition and precisely deliver highly potent molecules to critically ill patients. MicroCHIPS' drug delivery and biosensing devices have the potential to revolutionize monitoring and therapy for millions of patients suffering from metabolic and cardiovascular diseases."

Makoto Kaneshiro, Managing Director of CSK Venture Capital, added, "MicroCHIPS is targeting solutions to address the global epidemics of diabetes, osteoporosis and cardiovascular diseases. MicroCHIPS' unique technologies will provide significant advantages for these worldwide health problems."

"This latest round of financing underscores the great market potential for MicroCHIPS' biosensing and drug delivery technology," stated John Santini, MicroCHIPS' CEO. "Novartis' leadership in pharmaceutical development complements the medical device investment of Medtronic and Boston Scientific as MicroCHIPS develops solutions to help patients with debilitating diseases. CSK Venture Capital's experience as a pioneer of life science investments in Japan completes a global team of top investors."

About MicroCHIPS
MicroCHIPS, Inc. is pioneering 'smart' implantable devices to create sophisticated monitoring and therapy systems. Based on breakthrough technologies originally developed at MIT, MicroCHIPS' patented technologies have the ability to revolutionize today's medical implants by adding unique monitoring and targeted therapeutic capabilities designed to improve patient care in chronic disease states. MicroCHIPS' devices under development are based on advances the company has made in the fields of microelectromechanical systems (MEMS), implant technologies, drug formulation and chemical sensing. www.mchips.com

About Novartis Venture Fund
Novartis Venture Fund established in 1996, currently manages over $550 million in committed capital and is invested in more then 50 private companies. As a financially driven corporate life science investor, NVF invests in companies which have the potential to lead the next innovation wave in core therapeutic fields or explore new business areas that will be critical to patient care. The primary interest is in the development of novel therapeutics and platforms and is augmented with investments in medical devices, diagnostics, biomarkers and delivery systems. The Fund prefers to invest in the early-stages of company development and is able to lead, co-lead or participate in a larger syndicate. The NVF team of nine investment professionals located in Basel, Switzerland and Cambridge, MA brings together extensive experience in pharmaceutical R&D and venture capital. www.venturefund.novartis.com

About CSK Venture Capital
CSK Venture Capital is one of the oldest and most successful Japanese venture capital firms, and is located in Tokyo and Menlo Park, CA. Part of CSK Holding, the largest, independent IT service provider in Japan, CSK Venture Capital has invested in more than 200 companies in Japan, US, Europe, Israel, and Korea both in the technology and in the life science sector since 1991. CSK Venture Capital was the first venture capital firm to raise a dedicated bio-incubation fund in Japan in 1999 with funding from Japanese government institutions and leading pharmaceutical companies. The fund has achieved superior returns for investors and the most successful biotech IPO in Japan. Since then CSK Venture Capital has expanded its life science investment focus outside Japan with a number of high profile investments in the US and a particular focus on personalized medicine. www.cskvc.co.jp/eng/index_eng.html

Cisco Announces Venture Capital Initiative in Russia

Cisco Systems® (NASDAQ: CSCO) today announced a venture capital initiative targeting the technology industry in Russia. Cisco will pursue direct investment opportunities into technology-related start-ups as well as investments into local venture capital teams targeting the technology industry. Last year, in anticipation of this investment initiative, Cisco hired a full-time investment manager based in Moscow.

To launch the initiative, Cisco also announced that it has made an investment in a leading Russian e-commerce site, Ozon. With tens of thousands of book, movie and music titles on offer, Ozon is helping to shape the future of consumer e-commerce in Russia.

Further details of the deal were not disclosed.
"While Russia has low Internet penetration in terms of percentage of its overall population, in absolute terms it has as many Internet users as some Western European countries," said Bob Agee, vice president, Cisco Russia. "The amount of technical talent in Russia shows that the country is ready to become more technologically advanced. Increased investment in communications infrastructure can help improve productivity, diversify the economy and increase the standard of living across the country."

"Our venture investment in Russia is a continuation of a global strategy that we've implemented in Europe, Israel, China and India, which is to invest in local start-ups and venture teams and help promote the growth of a local innovation economy," said Hilton Romanski, director, global corporate business development. "Ozon is the first in what we hope will be an expanding venture relationship between Cisco and Russian entrepreneurs and investment partners."

Over the past decade, Cisco has deployed over $1 billion in venture capital funds. Through a combination of direct and indirect funding vehicles, Cisco is a strategic investor in start-ups and funds around the world and focuses on finding and investing in companies that have innovative technologies and business models.

Monday, April 2, 2007

Teleca divests auSystems for SEK 822 million in cash – in addition, Teleca eliminates continued losses in Obigo

• Teleca divests auSystems to two buyers:
• Cybercom acquires the Swedish, Danish and Polish operations for SEK 730 million in cash, and
• Devoteam acquires the operations in France, Italy, Norway and UK for a total consideration of SEK 92 million in cash

• Teleca halts investments into renewal of Obigo product and write down the assets connected to Obigo. More than 200 employees in Sweden will be offered employment by Sony Ericsson Mobile Communications.

• Telecas board of directors plan to distribute SEK 570 - 630 million, corresponding to SEK 9 - 10 per share. Proposal to shareholders will be presented during April 2007.

• In the future Teleca will focus on mobile consulting with its entire business in the mobile device industry. Teleca Mobile Consulting has an excellent customer base, more than 2000 employees and a proven track record of profitability.

Today Teleca announce two major transactions. The divestment of auSystems and the reorganization of the Obigo products business.

In total: the divestment of auSystems and the changes in Obigo will result in an addition of SEK 784 million in cash into Teleca. Due to a write-down of goodwill and other items the impact on the Earnings for the period will be minus SEK 198 million in 2007. Losses in Obigo will be eliminated. In the future Teleca's business will be Mobile Consulting, which historically has exhibited a strong profitability.

René Svendsen-Tune, President & CEO of Teleca says: “With the divestment of auSystems and the removal of the financial burden from our product business, we have reached a very significant milestone. The new Teleca will be a focused global services company with an excellent customer base, good profitability and a strong balance sheet. We can now devote all our energy to strengthen the top-line and profitability of the new streamlined company. The mobile device industry is rapidly consolidating, and it will be crucial for us to continue the drive for scale and improved cost base”.



The divestment of auSystems to Cybercom and Devoteam

The Cybercom transaction
Teleca will sell to Swedish Cybercom all its shares in auSystems' four Swedish subsidiaries (with offices in Stockholm, Malmö, Göteborg, Huskvarna, Linköping, Karlskrona, Östersund, Örnsköldsvik) and in Copenhagen, Denmark and the subsidiary in Poland (with offices in Warszawa and Lodz). In total these units employ approx. 750 people. The purchase price from Cybercom, paid in cash, totals SEK 730 million for a debt free company. The turnover of the auSystems Swedish and Polish subsidiaries in 2006 was approx. SEK 700 million and earnings before interest and tax (EBIT) was SEK 33 million. Excluding restructuring cost and management fees from Teleca, EBIT was SEK 54 million Before the end of April 2007 the parties will enter into an agreement which is expected to lead to future tax savings for Cybercom. The benefit of these savings will be split equally between Teleca and Cybercom implying an expected additional payment of SEK 14 million for Teleca.

The transaction is subject to shareholders approval from Telecas and Cybercoms shareholders. The companies' largest shareholders, Danir AB and JCE-Group AB have made irrevocable commitments to vote in favour of the transaction at these meetings. Danir AB controls 17.7% of total votes in Teleca. JCE-Group AB controls 41.8% of the total number of votes in Cybercom. Teleca and Cybercom will hold their extraordinary general meetings on 18 April 2007.

The Devoteam transaction
Teleca will sell to French Devoteam all its shares in the four international auSystems subsidiaries, with offices in Grimstad, Norway, Winchester, England, Paris, France, Milan and Rome, Italy. In total, these units employ approx 570 people. The purchase price of SEK 92 million for a debt free company is paid in cash. The turnover of these international auSystems subsidiaries in 2006 was SEK 500 million; earnings before interest and tax (EBIT) were SEK 0 million. Excluding restructuring costs and management fees from Teleca, EBIT was SEK 26 million.

Additional information
In total, these transactions will give rise to a capital gain of SEK 378 million in Teleca and add SEK 814 million in cash including transaction costs but excluding cash from future tax benefits. As a consequence of the transaction, deferred tax assets of SEK 94 million will be written down. auSystems result for the first quarter and the result of the transactions will be reported as discontinued operations in Telecas financial reports for 2007.

The Board of Directors of Teleca has concluded based on the process carried out that the sale of auSystems to Cybercom and Devoteam is the best possible outcome of an industrial sale of auSystems. Teleca's advisors HDR Partners has concluded, based on an overall assessment, that the achieved purchase price is in the range of what an IPO of auSystems would bring. Teleca's Board of Directors is of the opinion that the presented transaction is preferable to a later separate listing of auSystems, and hence recommends its shareholders to vote in favour of the transaction. In addition this solution provides auSystem with a stable and professional ownership structure for the benefit of auSystems customers and employees.

Teleca will evaluate the possibility to wind down auSystems remaining subsidiaries in Spain and Portugal with approximately 48 employees.

auSystems was formed in 2006 by the merger of two Teleca divisions: Operators and Network Equipment Providers. Originally, the company has its roots in Sigma and AU-System, where AU-System was formed already in 1974. auSystems offers traditional IT consultancy services, testing, research and development. Customers are primarily found within Network Equipment Providers, Operators, Media, Automotive, Government and large enterprises. auSystems has 1 367 employees in eight European countries as of February 28 2007. The turnover of auSystems in 2006 was SEK 1,359 million and earnings before interest and tax (EBIT) were SEK 25 million.


Teleca halts investments into renewal of the Obigo products

Product investments will be discontinued - maintenance & services will continue
During 2006 Teleca?s product business had revenues of SEK 227 million and EBIT of minus SEK 218 million. Excluding restructuring EBIT was minus SEK 161 million.

On the backdrop of recent significant changes in OEM and operator strategies, Teleca has decided to eliminate the risk of continued losses in its Obigo product business. Teleca will discontinue its own investments into the software products and continue the business under a services model. Teleca will open its source code to customers in order to drive the change from a product to a services model.

Teleca will maintain and support the existing software from its offices in Korea and Russia. Customers will be served from all relevant Teleca affiliates.

Teleca will close its product development and integration centre in Lund-Malmö, Sweden.

Teleca will fulfil all customer commitments, and work closely with customers to secure good leverage of investments made and successful completion of existing projects. This way Teleca will seek to mitigate impacts to service revenues outside Sweden.

Cooperation with Sony Ericsson secures more than 200 jobs in Lund-Malmö
Teleca has initiated cooperation with Sony Ericsson Mobile Communications. Due to the expansion of Sony Ericsson and their need for additional staff, more than 200 Teleca employees will be offered employment by Sony Ericsson. Further the parties have agreed on terms securing Teleca a preferred supplier status for Sony Ericsson in Sweden.

Teleca will take one-time charges of SEK 482 million related to Obigo, whereof SEK 30 million has cash effect
Teleca will take a one-time charge including write-down of goodwill of SEK 352 million, write-down of capitalized R&D of SEK 100 million, and restructuring expenses of SEK 30 million, in total SEK 482 million. This will eliminate the negative results in the products business. There will be no goodwill related to the product business and the remaining capitalized R&D will amount to SEK 22 million for the products. The restructuring expenses are preliminary and for instance depending upon how many employees that accepts the employment offers. This will be more specified in Teleca?s Q1 report.


Teleca Board of Directors plans to distribute SEK 9?10 per share to shareholders

The Board of Directors in Teleca plans a distribution of SEK 570?630 million to Teleca's shareholders through a share redemption program. The amount will be decided during April 2007, when the restructuring cost is calculated in detail. Teleca will call for an extraordinary general meeting to decide on the distribution. Details of the redemption program will be presented in due time before the shareholder's meeting. The redemption approach is selected to allow shareholders to follow normal capital gains taxation principles.

Teleca's balance sheet

Teleca preliminary pro-forma balance sheet of December 31 2006, including the sale of auSystems, write-down of products, offer of employments by Sony Ericsson and distribution to shareholders of 570 or 630 million, is shown in appendix 1.


Teleca going forward: Mobile Consulting

After these transactions the transformation of Teleca towards a profitable and focused services and software solutions company has been completed. The new Teleca has its entire business focus in the mobile device industry. It has an excellent customer base, and a list of global leaders as partners.

The company will have a strong balance sheet and a good profitability after bringing the Obigo business to maintenance mode. Teleca Mobile Consulting had revenues during 2006 of SEK 1,477 million and EBIT of SEK 113 million. Excluding effects from losses related to BenQ Germany's bankruptcy petition, EBIT was SEK 159 million.

The units in Russia, Germany, Sweden, Finland and UK, which is about 80% of the total number of employees, will be practically unaffected by the changes in Obigo. They all have a strong customer base and deliver services with very good margins based on strong competencies and strong customer relationships. The service business in Asia is quite closely linked to Teleca?s product business, and it will need to adapt to the new situation over the next quarters.
Teleca will invest into building competences around Open Source Software. The initial work will be performed in Sweden, but over time Teleca plans to make use of its competences in low cost countries. Teleca expects a significant services market to open around Open Source Software.

Financial impact and outlook
For 2007, Teleca Mobile expects declining revenues compared to 2006 in both products and services as a consequence of the changes in Obigo.
Product revenue from maintenance and ongoing royalties today at a level of SEK 80 million annually, is expected to decline rapidly but to continue into 2008. Cost is over time expected to be lower than expected revenues.
The product integration centre in Sweden contributed in 2006 with revenue of SEK 90 million, with slightly negative EBIT margin. This source of revenue will practically be removed in 2007. This will affect the revenue growth for the services business in 2007, but it will have a positive effect on the margins. A small part of Teleca's services business, that is Sweden, Korea and US/UK, will be significantly negatively impacted in Q1 and Q2 of 2007 due to the changes in the Obigo business.
Due to a write-down of goodwill and other items the impact on the Earnings for the period will be minus SEK 198 million in 2007
After the initiated changes, Teleca targets a margin above 10% in Q3 and Q4 2007. Margin in Q1 and Q2 is negatively impacted by the changes in Obigo.

Financial adviser
HDR Partners has been financial adviser to Teleca.



Teleca is a world-leading supplier of software products and services to the mobile devices industry. Services include system design and the integration of software and hardware for mobile phones; there are also tailored solutions. Teleca consists of 2,200 experts in 11 countries in Asia, Europe and North America. Teleca is listed on the Mid Cap list on the Nordic Exchange. www.teleca.com

Comcast Interactive Capital Invests in Vyatta

Vyatta today announced it has completed its Series B financing led by Comcast Interactive Capital (CIC). In addition to leading the round, CIC has joined the Vyatta board of directors, where it will assist the company in addressing service provider market opportunities for its open-source networking solutions that include routing, firewall, and VPN functionality as well as extensibility for many other network applications.

Comcast Interactive Capital was joined in the new funding round by all of Vyatta’s existing investors, including JPMorgan Partners (as advised by Panorama Capital), ComVentures, and ArrowPath Venture Partners, bringing the total venture funding in Vyatta to $18.5 million. The funds will be used for operating capital as the company scales its market penetration and product delivery.

“This investment by Comcast Interactive Capital provides further validation of Vyatta’s vision,” said Kelly Herrell, CEO of Vyatta. “Whether deployed by enterprises or delivered as premise equipment by service providers, the network infrastructure market is at the beginning of a profound wave of change driven by the power of openness. Vyatta is poised to capitalize on this dynamic, and we look forward to working with Comcast Interactive Capital as we drive this change.”

Vyatta was created to bring commercial-quality, open-source networking products to market. The company is staffed by industry veterans, serial entrepreneurs, and some of the brightest minds in the open source and networking industries who share a passion for flexible, low-cost networking products that allow users to create highly-reliable infrastructure. The Vyatta system is available as a software subscription with tiered service and support options, or as a pre-configured hardware appliance that can be easily dropped into a network. Vyatta has also sponsored the Vyatta Community, a public forum for Vyatta users and developers who are interested in open-source network innovation. For more information on Vyatta products, visit: http://www.vyatta.com/products/plans.php